Global Peptide Therapeutics Industry and Competitive Landscape Analytics 2021-2026 Featuring Profiles of Major Vendors, Including Teva Pharma, Novo Nordisk, Eli Lilly, Takeda Pharma, and GSK
15 oct. 2021 04h43 HE
|
Research and Markets
Dublin, Oct. 15, 2021 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market by Application, Drug Type, Type of Manufacturing, Synthesis Technology, Solid Phase Peptide Synthesis, and Hybrid...
Global Peptide Therapeutics Markets, 2021-2026 - New Drug Discovery and Product Launches in Chronic Metabolic Disorders Would Provide Fruitful Opportunities
05 oct. 2021 07h08 HE
|
Research and Markets
Dublin, Oct. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market (2021 Edition) - Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced),...
Global Peptide Drug Conjugate Market Opportunity 2026 US Europe Japan South Korea Sales Forecast 2026
17 avr. 2021 05h09 HE
|
KuicK Research
DELHI, India, April 17, 2021 (GLOBE NEWSWIRE) -- Global Peptide Drug Conjugate Market and Clinical Trials Insight 2026 Report Highlights: First FDA Approved Peptide Drug Conjugate: Pepaxto...
C3 Jian Adds Two Top Oral Healthcare Professionals to Its Board of Directors
10 nov. 2014 06h00 HE
|
C3 Jian, Inc.
LOS ANGELES, Nov. 10, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare through new pharmaceutical products, announced the appointment of Steven...
C3 Jian Closes $60M Series D Financing
17 mars 2014 15h12 HE
|
C3 Jian, Inc.
LOS ANGELES, March 17, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on developing proprietary drugs with an initial focus on improving oral healthcare, announced today the close...
C3 Jian Appoints Richard Bastiani to Board of Directors
04 oct. 2012 17h19 HE
|
C3 Jian, Inc.
LOS ANGELES, Oct. 4, 2012 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced the appointment of Richard Bastiani, Ph.D., as a member of its...
C3 Jian Obtains FDA Acceptance of Investigational New Drug Application
24 mai 2012 12h06 HE
|
C3 Jian, Inc.
LOS ANGELES, May 24, 2012 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that its Investigational New Drug Application (IND) for...
C3 Jian Appoints Senior Director of Clinical Operations
28 mars 2012 18h45 HE
|
C3 Jian, Inc.
LOS ANGELES, March 28, 2012 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that Siegfried S. Rogy, Ph.D. has been appointed Senior...
C3 Jian Appoints Vice President Product Development
01 mars 2012 17h42 HE
|
C3 Jian, Inc.
LOS ANGELES, March 1, 2012 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that Brian C. Varnum, Ph.D., has been appointed Vice...
Vestaron Corporation Receives FNIH Grant for Malaria Control Research
24 août 2011 12h42 HE
|
Vestaron Corporation
KALAMAZOO, MI--(Marketwire - Aug 24, 2011) - Vestaron Corporation, a venture-backed agricultural biotechnology company based in Kalamazoo, MI, has been awarded a $1.4 million grant from the...